Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

232
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
232
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

326
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
326
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

395
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
395
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

221
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
221
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

326
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
326
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

198
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
198

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Trends and Outcomes in Transcatheter Aortic Valve Implantation: a report from the SwissTAVI Registry.

Cardiovascular intervention and therapeutics·2026
Same author

Comparison of Cardiac Troponin T and I: Impact on Definitions of Perioperative Myocardial Infarction After Coronary Artery Bypass Grafting.

Journal of the American Heart Association·2026
Same author

Cardiac Rhythm and Conduction Abnormalities in Aircrew.

Aerospace medicine and human performance·2026
Same author

Coronary Artery Disease Detection and Disposition in Aircrew.

Aerospace medicine and human performance·2026
Same author

Structural Heart Disease in Aircrew.

Aerospace medicine and human performance·2026
Same author

The Role of Packaged Red Blood Cells Administration on Long-term Outcomes in Patients Who Underwent Transcatheter Aortic Valve Implantation.

The Canadian journal of cardiology·2025

Related Experiment Video

Updated: Jan 2, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Pilot licensing after aortic valve surgery.

Thomas Syburra1, Hans Schnüriger, Barbara Kwiatkowski

  • 1Cardiac Surgery Department, City Hospital Triemli, Zurich, Switzerland. thomas.syburra@triemli.stzh.ch

The Journal of Heart Valve Disease
|June 30, 2010
PubMed
Summary

Pilots with bicuspid aortic valves can return to flight after aortic valve replacement, but with specific restrictions on G-force exposure and aircraft type. Regular cardiac monitoring is essential for continued flight eligibility.

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K

Related Experiment Videos

Last Updated: Jan 2, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K

Area of Science:

  • Cardiology
  • Aerospace Medicine
  • Regulatory Affairs

Background:

  • Bicuspid aortic valve is the most common congenital heart defect, often leading to complications.
  • Aortic valve replacement (AVR) in pilots presents unique challenges for flight licensing and aeromedical certification.
  • High G-load environments in aviation require special consideration for pilots post-AVR.

Observation:

  • A review of aeronautical, surgical, and medical literature examined European pilot licensing regulations.
  • Case studies of two Swiss Air Force pilots undergoing AVR were analyzed.

Findings:

  • European regulations permit return to flight duty six months post-AVR with bioprostheses, provided no cardiac dysfunction or medication is needed.
  • Limitations include co-pilot requirement, restricted to +3 Gz acceleration, and non-ejection-seat aircraft for military pilots.
  • Mechanical prostheses are disqualifying due to mandatory anticoagulation therapy.

Implications:

  • Pilot licensing post-AVR is feasible but requires adherence to strict limitations, particularly concerning G-force exposure.
  • Bioprosthesis choice (pericardial, stentless) is critical for optimal performance in high-output conditions.
  • Mandatory, regular cardiological follow-up is crucial for early detection of valve degeneration and rhythm disturbances, guiding timely reoperation.